ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 172 filers reported holding ACCELERON PHARMA INC in Q3 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $6,040,000 | -58.2% | 63,401 | -76.8% | 0.04% | -48.7% |
| Q4 2019 | $14,466,000 | +628.4% | 272,841 | +442.9% | 0.08% | +533.3% |
| Q3 2019 | $1,986,000 | -93.8% | 50,256 | -93.5% | 0.01% | -92.8% |
| Q2 2019 | $31,869,000 | +37.5% | 775,768 | +55.9% | 0.17% | +59.0% |
| Q1 2019 | $23,178,000 | -28.6% | 497,700 | -33.2% | 0.10% | -33.5% |
| Q4 2018 | $32,449,000 | +4249.7% | 745,100 | +5619.2% | 0.16% | +5166.7% |
| Q3 2018 | $746,000 | -72.6% | 13,028 | -82.1% | 0.00% | -75.0% |
| Q3 2017 | $2,721,000 | -43.7% | 72,900 | -60.1% | 0.01% | -55.6% |
| Q1 2017 | $4,837,000 | – | 182,741 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |